During the past decade, Kailiang Wu conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Kailiang Wu" are "Thymoma and Thymic Carcinoma" (2 trials) and "Thymoma" (1 trials). Many other conditions were trialed in "Kailiang Wu" in a lesser frequency.

Most popular intervention types in "Kailiang Wu" are "Radiation" (3 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cisplatin" (1 trials), "Etoposide" (1 trials), "adjuvant radiotherapy" (1 trials), "concurrent chemoradiation" (1 trials) and "radiotherapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kailiang Wu" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Kailiang Wu". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Kailiang Wu, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kailiang Wu, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".